CRWV vs PG: Which Is the Better Buy?
Side-by-side comparison of CoreWeave, Inc. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
CoreWeave, Inc. · Technology
$89.89
+24.6% upside to fair value
Med Conviction
Grade C+
VS
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRWV has more upside to fair value
(+24.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWV |
PG |
| Current Price |
$89.89 |
$150.38 |
| Fair Value Estimate |
$112.00 |
$165.39 |
| Upside to Fair Value |
+24.6%
|
+10.0%
|
| Market Cap |
$49.0B |
$350.2B |
| Forward P/E |
—
|
21.5x
|
| EV / EBITDA |
26.6x
|
15.1x
|
| Price / Sales |
7.9x
|
4.0x
|
| Price / FCF |
—
|
23.3x
|
| Revenue Growth YoY |
+111.6%
|
+7.4%
|
| Gross Margin |
69.4%
|
50.3%
|
| Operating Margin |
-2.6%
|
23.2%
|
| Return on Equity |
-33.5%
|
31.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
-21.6%
|
4.29%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
CoreWeave is the leading neocloud, a GPU-specialized cloud infrastructure provider built to serve the compute-hungry demands of generative AI training and inference. Since its March 2025 IPO, revenue has scaled roughly 112% year over year to $2.08 billion in the first quarter of 2026, backed by a $99.4 billion contracted revenue backlog and marquee agreements with Microsoft, OpenAI, Meta, Anthrop…
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
| Metric |
CRWV |
PG |
| Zone Low |
$84.00 |
$124.04 |
| Zone High |
$95.00 |
$140.58 |
| In Buy Zone? |
Yes
|
No
|